The treatment of chronic maxillary sinusitis by inhalation therapy with bisolvon.
D000328:Adult; D000336:Aerosols; D000814:Aniline Compounds / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002908:Chronic Disease; D003510:Cyclohexanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005100:Expectorants / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008443:Maxillary Sinus; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011859:Radiography; D012852:Sinusitis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology
D000336:Aerosols; D000814:Aniline Compounds; D000900:Anti-Bacterial Agents; D001593:Benzyl Compounds; D003510:Cyclohexanes; D005100:Expectorants; D000644:Quaternary Ammonium Compounds